Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer

被引：0
|
作者：
Litaty C. Mbatchi
Matthieu Gassiot
Philippe Pourquier
Alejando Goberna
Hakim Mahammedi
Loic Mourey
Florence Joly
Serge Lumbroso
Alexandre Evrard
Nadine Houede
机构：
[1] CHU Nîmes,Laboratoire de Biochimie et Biologie Moléculaire
[2] Hôpital Carémeau,Laboratoire de Pharmacocinétique, Faculté de Pharmacie
[3] IRCM,Département de Recherche Clinique et d’Epidémiologie
[4] Institut de Recherche en Cancérologie de Montpellier,Département d’Oncologie Médicale
[5] INSERM U1194,Département d’Oncologie Médicale
[6] Université de Montpellier,Département d’Oncologie Médicale
[7] Institut Bergonié,Département d’Oncologie Médicale
[8] Centre Jean Perrin,undefined
[9] IUCT Oncopole,undefined
[10] Centre François Baclesse,undefined
[11] CHU Nîmes,undefined
[12] Hôpital Carémeau,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Temsirolimus; Pharmacogenetics; NR1I2; CYP3A5; ABCB1; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：653 / 659
页数：6
相关论文
共 50 条
  • [31] Effect of genetic variants in CYP2C8, CYP3A4, CYP3A5, and ABCB1 on paclitaxel pharmacokinetics.
    Sparreboom, A
    Marsh, S
    Henningsson, A
    Karlsson, MO
    Garsa, A
    Loos, WJ
    Verweij, J
    McLeod, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 139S - 139S
  • [32] Association of variants in ABCB1 and CYP3A5 with carbamazepine exposure: Racial differences
    Kijsanayotin, Pornpimol
    Leppik, I. E.
    Oetting, W. S.
    Birnbaum, A. K.
    Marino, S. E.
    Ramsay, R. E.
    Rarick, J. O.
    Prasittisopin, B.
    Pennell, P. B.
    White, J. A.
    Cloyd, J. C.
    EPILEPSIA, 2007, 48 : 378 - 379
  • [33] Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
    Belmonte, Carmen
    Ochoa, Dolores
    Roman, Manuel
    Saiz-Rodriguez, Miriam
    Wojnicz, Aneta
    Isabel Gomez-Sanchez, Clara
    Martin-Vilchez, Samuel
    Abad-Santos, Francisco
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (06) : 596 - 605
  • [34] Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1
    Yoo, Hee-Doo
    Cho, Hea-Young
    Lee, Yong Bok
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (01) : 27 - 37
  • [35] Association of genetic variants in ABCB1 and CYP3A4/5 with the pharmacokinetics of erlotinib.
    Scripture, CD
    Sissung, TM
    Permenter, MG
    Price, DK
    Swain, SM
    Sparreboom, A
    Figg, WD
    PHARMACOTHERAPY, 2005, 25 (10): : 1480 - 1480
  • [36] Impact of CYP3A5 and ABCB1 Genotype On The Pharmacokinetics of Prednisolone in Renal Transplant Recipients
    Elnahhas, T.
    Moreton, M.
    Lee, T.
    McKeown, D.
    Popoola, J.
    Ramkhelawon, R.
    Johnston, A.
    MacPhee, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 548 - 549
  • [37] Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients
    Litaty Céphanoée Mbatchi
    Jacques Robert
    Marc Ychou
    Jean-Christophe Boyer
    Maguy Del Rio
    Matthieu Gassiot
    Fabienne Thomas
    Nicole Tubiana
    Alexandre Evrard
    Clinical Pharmacokinetics, 2016, 55 : 1145 - 1157
  • [38] Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients
    Mbatchi, Litaty Cephanoee
    Robert, Jacques
    Ychou, Marc
    Boyer, Jean-Christophe
    Del Rio, Maguy
    Gassiot, Matthieu
    Thomas, Fabienne
    Tubiana, Nicole
    Evrard, Alexandre
    CLINICAL PHARMACOKINETICS, 2016, 55 (09) : 1145 - 1157
  • [39] The distribution of genetic polymorphism of CYP3A5, CYP3A4 and ABCB1 in patients subjected to renal transplantation
    Vavic, Neven
    Rancic, Nemanja
    Cikota-Aleksic, Bojana
    Magic, Zvonko
    Cimesa, Jelena
    Obrencevic, Katarina
    Radojevic, Milorad
    Mikov, Momir
    Dragojevic-Simic, Viktorija
    VOJNOSANITETSKI PREGLED, 2016, 73 (07) : 663 - 667
  • [40] INFLUENCE OF CYP3A5*3 AND ABCB1 POLYMORPHISMS ON CHRONIC DAMAGE IN KIDNEY PROTOCOL BIOPSIES
    Vidal, Anna
    Fontova, Pere
    Elens, Laure
    Hesselink, Dennis A.
    vanSchaik, Ron
    vanGelder, Teun
    Bestard, Oriol
    Melilli, Edoardo
    Montero, Nuria
    Cerezo, Gema
    Torras, Joan
    Cruzado, Josep M.
    Grinyo, Josep M.
    Lloberas, Nuria
    TRANSPLANT INTERNATIONAL, 2019, 32 : 61 - 61
12345